Press
Press Release
Press release : green light from ANSM pour the clinical trial MUCOBOOST, phase 1 and 2.
Click the link to access the press release (in french) of March 14, 2025.
The replay of the press conference of January 20, 2022 (French)
Click the link to watch the replay of the press conference on the nasal vaccine carried out by the BioMAP research team (UMR INRAE – University of Tours – Infectiology and Public Health), which took place on January 20, 2022.
Communiqué de presse (20 janvier 2022 - version française)
Press Release (20 January 2022 - English version)
Lovaltech winner of the 24th i-lab competition
Lovaltech ranks 11th and obtains a financial support of 375 000 € which will make it possible to support a part of the toxicity study of the development plan of the vaccine.
Press Release i-lab (juillet 2022)
They talked about us ...
2026
La Nouvelle République : À Tours, une avancée pleine d’espoir : le vaccin nasal contre le Covid de Lovaltech ne produit « pas d’effets secondaires ni indésirables » – published 03/14/2026
2025
Ici : Tours : des premiers essais sur l'homme encourageants pour le vaccin nasal contre le Covid-19 – published 09/15/2025
2023
BFM Business : French Tech: LoValTech – published 09/05/2023
2022
Ouest France : Covid-19. Où en est le développement du vaccin par voie nasale ? – published 07/12/2022
Pharmaceutiques : LoValTech : l’espoir du vaccin nasal – published le 01/24/2022
La Nouvelle République : Top des entreprises 2022 en Indre-et-Loire – published le 12/12/2022
Revues scientifiques :
Nature
Numérama sciences
Pharmaceutiques
Sciences et Avenir
Science Translation Medecine
Communication
LoValTech makes the following photographs available to you.
You are authorized to publish them by taking care to respect the legal mention (name of the institute and the author) in its entirety, under the form: INRAE / Name and surname.
Do not hesitate to consult the details of our general conditions of use (authorized and prohibited uses) at the following address
https://mediatheque.inrae.fr/INRAE/info2.do
Thank you for your interest, we remain at your disposal, the image service.